/
 Ventricular Arrhythmia Dr  Ventricular Arrhythmia Dr

Ventricular Arrhythmia Dr - PowerPoint Presentation

lindy-dunigan
lindy-dunigan . @lindy-dunigan
Follow
346 views
Uploaded On 2020-04-04

Ventricular Arrhythmia Dr - PPT Presentation

Mostafa Hekmat Cardiologist Electrophysiologist VENTRICULAR TACHYCARDIA VT Arises Distal To The Bifurcation Of The HB In The Specialized Conduction System In The Ventricular Muscle Or In Combination Of Both Tissues ID: 775331

mostafa hekmat ventricular patients mostafa hekmat ventricular patients qrs premature wave lqts rhythm complex rate pvc cardiac treatment heart

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " Ventricular Arrhythmia Dr" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Ventricular Arrhythmia

Dr

Mostafa Hekmat

Cardiologist

Electrophysiologist

Slide2

VENTRICULAR TACHYCARDIA

VT Arises Distal To The Bifurcation Of The HB In The Specialized Conduction SystemIn The Ventricular MuscleOr In Combination Of Both Tissues

Dr Mostafa Hekmat

2

Slide3

Note

Any wide QRS complex tachycardia should be treated as ventricular tachycardia until definitive evidence is found to establish another diagnosis

Dr Mostafa Hekmat

3

Slide4

Types of Ventricular Arrhythmia

Premature Ventricular ComplexesVentricular TachycardiaMonomorphicPolymorphicTorsade de pointNormal QTVentricular FlutterVentricular Fibrillation

Dr Mostafa Hekmat

4

Slide5

Ventricular ArrhythmiasDefinitions

Premature Ventricular beatsSingle beatsVentricular Bigeminy, the appearance of one PVC after each sinus beatCouplets, two consecutive premature beatsTriplets, three consecutive premature beatsSalvos, runs of 3-10 premature beats

Dr Mostafa Hekmat

5

Slide6

Ventricular ArrhythmiasDefinitions

Accelerated Idioventricular Rhythm (Slow VT), rate 60-100 bpm Ventricular Tachycardia (VT), rate over 100 bpm Ventricular Flutter, regular large oscillations at a rate of 150-300 bpmVentricular Fibrillation (VF), irregular undulations of varying contour and amplitude

Dr Mostafa Hekmat

6

Slide7

PVC

Dr Mostafa Hekmat

7

60 bpm

Rate?

Regularity?

Occasionally irreg.

None for 7

th QRS

0.08 s (7th wide)

P waves?

PR interval?

0.14 s

QRS duration?

Interpretation?

Sinus Rhythm with 1 PVC

Slide8

VT

Dr Mostafa Hekmat

8

160 bpm

Rate?

Regularity?

Regular

None

Wide (> 0.12 sec)

P waves?

PR interval?

None

QRS duration?

Interpretation?

Ventricular Tachycardia

Slide9

VF

Dr Mostafa Hekmat

9

None

Rate?

Regularity?

Irregularly irreg.

None

Wide, if recognizable

P waves?

PR interval?

None

QRS duration?

Interpretation?

Ventricular Fibrillation

Slide10

Premature Ventricular Complexes

Premature occurrence of a QRS complex that is abnormal in shapeDuration usually exceeding the dominant QRS complex Generally longer than 120 millisecondsThe T wave is usually large and opposite in direction to the major deflection of the QRSA fully compensatory pause usually follows a PVCThe PVC may not produce any pause and may therefore be interpolated

Dr Mostafa Hekmat

10

Slide11

Dr Mostafa Hekmat

11

Slide12

Ventricular fusion beat

Dr Mostafa Hekmat

12

Slide13

PVC and ventricular echo

Dr Mostafa Hekmat

13

Slide14

An interpolated PVC

Dr Mostafa Hekmat

14

Slide15

Ventricular Premature Complexes

Dr Mostafa Hekmat

15

Compensatory Pause

Interpolated VPC

Slide16

Premature Ventricular Complexes

Bigeminy Pairs of complexes and indicates a normal and premature complexTrigeminy Premature complex that follows two normal beatsQuadrigeminyPremature complex that follows three normal beats is called

Dr Mostafa Hekmat

16

Slide17

PVC

Pair or couplet Two successive PVCsTriplet Three successive PVCsVentricular tachycardia Three or more successive PVCsPVCs can have different contoursMultifocal Multiform PolymorphicPleomorphic

Dr Mostafa Hekmat

17

Slide18

Multiform

Dr Mostafa Hekmat

18

Slide19

Salvos

Dr Mostafa Hekmat

19

Slide20

PVC

Fixed couplingReentry Triggered activityVariable couplingParasystole Changing conduction in a reentrant circuitChanging discharge rates of triggered activity

Dr Mostafa Hekmat

20

Slide21

CLINICAL FEATURES

The prevalence of premature complexes increases with ageMale genderHypokalemiaPVCs are more frequent in the morning in patients after MIThis circadian variation is absent in patients with severe left ventricular (LV) dysfunction.

Dr Mostafa Hekmat

21

Slide22

CLINICAL FEATURES

Activity that increases the heart rate can decreaseThe patient’s awareness of the premature systolesReduce their number.SleepUsually associated with a decrease in the frequency of ventricular arrhythmiasBut some patients can experience an increase.

Dr Mostafa Hekmat

22

Slide23

The importance of PVCs

Depends on the clinical settingIn the absence of underlying heart disease, the presence of PVCs usually has no impact on longevity or limitation of activityAntiarrhythmic drugs are not indicatedPatients should be reassured if they are symptomatic

Dr Mostafa Hekmat

23

Slide24

PVC and MI

Those occurring close to the preceding T waveMore than five or six per minuteBigeminal or multiform complexesThose occurring in salvoes of two or three or moreDo not occur in about 50% of patients in whom VF developsAnd VF does not develop in about 50% of patients who have these PVCsThus, these PVCs are not particularly helpful prognostically

Dr Mostafa Hekmat

24

Slide25

Idioventricular Rhythm

Dr Mostafa Hekmat

25

Slide26

Accelerated idioventricular rhythm

Dr Mostafa Hekmat

26

Slide27

Dr Mostafa Hekmat

27

Slide28

ECG Distinction of VT from SVT with Aberrancy

Favors VT Favors SVT with Aberrancy

Dr Mostafa Hekmat

28

Morphology Precordial concordance

If LBBB: V

1

duration > 30

ms

S wave > 70

ms

S wave notched or slurred

V

6

:

qR

or QR R wave monophasic

If RBBB: V

1

: monophasic R wave

qR

If

triphasic

, R > R

1

R < R

1

V

6

: R < S

Slide29

VENTRICULAR FLUTTER & VENTRICULAR FIBRILLATION

Dr Mostafa Hekmat

29

Slide30

A-V Dissociation, Fusion, and

Capture Beats in VT

Dr Mostafa Hekmat

30

ECTOPY

FUSION

CAPTURE

V1

E

F

C

Slide31

Accelerated Idioventricular Rhythm

The arrhythmia occurs as a rule in patients who have heart disease, such as those with acute myocardial infarction or with digitalis toxicity.Reperfusion of a previously occluded coronary artery During resuscitationIt is transient and intermittentEpisodes lasting a few seconds to a minuteDoes not appear to seriously affect the patient’s clinical course or the prognosis

Dr Mostafa Hekmat

31

Slide32

Therapy when

Considered when AV dissociation results in loss of sequential AV contractionAn accelerated idioventricular rhythm occurs together with a more rapid VTAn accelerated idioventricular rhythm begins with a PVC discharging in the vulnerable period of the preceding T waveThe ventricular rate is too rapid and produces symptomsVF develops as a result of the accelerated idioventricular rhythm.

Dr Mostafa Hekmat

32

Slide33

Therapy

Increasing the sinus rate with Atropine or atrial pacing suppresses the accelerated idioventricular rhythm

Dr Mostafa Hekmat

33

Slide34

Dr Mostafa Hekmat

34

Slide35

Clinical Impact of VT/VF

PVCs and even runs of nonsustained VT may be frequently seen in people with normal and abnormal heartsSustained VT and VF usually develop in patients with advanced structural heart disease

Dr Mostafa Hekmat

35

Slide36

Clinical Impact of VT/VF

Frequent PVCs in the recovery phase after an exercise test are stronger predictors of mortality than ventricular extrasystoles during exercisePredicts an increased mortality in systolic heart failure patientsPost exercise severe ventricular ectopyTripletsNonsustained VTSustained VTSustained VF

Dr Mostafa Hekmat

36

Slide37

Clinical Impact of VT/VF

CAD is the most frequent cause of SCD and clinically documented VT and VF 80%There is no reason to neglect the device even if the stable VT has been successfully ablated

Dr Mostafa Hekmat

37

Slide38

VT + RBBB

(1) the QRS complex is monophasic or biphasic in V1, with an initial deflection different from that of the sinus-initiated QRS complex(2) the amplitude of the R wave in V1 exceeds the R′(3) a small R and large S wave or a QS pattern in V6 may be present.

Dr Mostafa Hekmat

38

Slide39

VT + LBBB

(1) the axis can be rightward, with negative deflections deeper in V1 than in V6,(2) a broad prolonged (more than 40 milliseconds) R wave in V1(3) a small Q–large R wave or QS pattern in V6 can exist

Dr Mostafa Hekmat

39

Slide40

VT

QRS duration exceeding 140 millisecondsIn precordial leads with an RS pattern, the duration of the onset of the R to the nadir of the S exceeding 100Fusion beatCapture beatAV dissociation has long been considered a hallmark of VTRetrograde VA conduction to the atria from ventricular beats occurs in at least 25% of patients

Dr Mostafa Hekmat

40

Slide41

Supraventricular arrhythmiawith aberrancy

(1) consistent onset of the tachycardia with a premature P wave(2) very short RP interval (0.1 sec) (3) QRS configuration the same as that occurring from known supraventricular conduction at similar rates(4) P wave and QRS rate and rhythm linked to suggest that ventricular activation depends on atrial discharge (an AV Wenckebach block) (5) slowing or termination of the tachycardia by vagal maneuvers

Dr Mostafa Hekmat

41

Slide42

Dr Mostafa Hekmat

42

Slide43

A QRS complex in V1 - V6,  either all negative or all positive  favors a VT The presence of a 2 : 1 VA block  VTPositive QRS complex in V1 - V6 can also occur from conduction over a left-sided accessory pathway.Supraventricular beats with aberrationTriphasic pattern in V1An initial vector of the abnormal complex similar to that of the normally conducted beatsWide QRS complex with long-short cycle sequence

Dr Mostafa Hekmat

43

Slide44

Sustained Monomorphic VT

Dr Mostafa Hekmat

44

Slide45

Dr Mostafa Hekmat

45

Slide46

Increased risk in VT

Reduced LV functionSpontaneous ventricular arrhythmiasLate potentials on signal-averaged ECGQT interval dispersionT wave alternansProlonged QRS durationHeart rate turbulenceInducible sustained VTs

Dr Mostafa Hekmat

46

Slide47

Treatment

Dr Mostafa Hekmat

47

Slide48

Treatment

Frequent PVCs, even in the setting of an acute MI, need not be treated unless they directly contribute to hemodynamic compromise

Dr Mostafa Hekmat

48

Slide49

Treatment

Beta blockers are often the first line of therapy.If they are ineffective, class IC drugs seem particularly successful in suppressing PVCsFlecainide and Moricizine have been shown to increase mortality in patients treated after MI Should be reserved for patients without coronary artery disease or LV dysfunctionAmiodaroneShould be reserved for highly symptomatic patients and those with structural heart disease.

Dr Mostafa Hekmat

49

Slide50

Treatment

VT that precipitatesHypotension Shock Angina Congestive heart failureSymptoms of cerebral hypoperfusionShould be treated promptly with DC cardioversionVery low energies can terminate VT  a synchronized shock of 10 to 50 J.Digitalis-induced VT is best treated pharmacologically.

Dr Mostafa Hekmat

50

Slide51

Thump Version

Can terminate VT by mechanically inducing a PVC that presumably interrupts the reentrant pathway necessary to support it.Chest stimulation at the time of the vulnerable periodCan accelerate the VT or Possibly provoke VF.Intermittent VT  best treated pharmacologically

Dr Mostafa Hekmat

51

Slide52

Treatment

In patients in whom procainamideIneffectiveProcainamide may be problematicSevere heart failureRenal failureIntravenous Amiodarone is often effectiveLoading dose of 15 mg/min is given during a 10-minute periodInfusion of 1 mg/min for 6 hoursMaintenance dose of 0.5 mg/min for the remaining 18 hours and for the next several days

Dr Mostafa Hekmat

52

Slide53

Reversible conditions

VT related to ischemia  antianginal Hypotension  vasopressorsHypokalemia  potassiumCorrection of HF  reduce the frequency of ventricular arrhythmiasSinus bradycardia or AV block  PVCs and ventricular tachyarrhythmias, which can be corrected by administrationAtropine Temporary isoproterenol administrationPacing

Dr Mostafa Hekmat

53

Slide54

Long-Term Therapy

Asymptomatic nonsustained ventricular arrhythmias in low-risk populations (preserved LV function) often need not be treated.In patients with symptomatic nonsustained tachycardia, beta blockers are frequently effective in preventing recurrences.In patients refractory to beta blockers, class IC agents, Sotalol, or Amiodarone can be effective

Dr Mostafa Hekmat

54

Slide55

CLASSIFICATION OF IDIOPATHIC MONOMORPHIC VT

Dr Mostafa Hekmat

55

Slide56

RMVT

Dr Mostafa Hekmat

56

Slide57

Both Forms Are Characterized By Adenosine SensitivityAnd Are Thought To Be Caused By Cyclic Amp Mediated Triggered Activity

Dr Mostafa Hekmat

57

Slide58

VT Can Be Terminated With Adenosine, Verapamil, The Valsalva Maneuver or CSP

Dr Mostafa Hekmat

58

Slide59

VERAPAMIL-SENSITIVE VT

Dr Mostafa Hekmat

59

Slide60

VERAPAMIL-SENSITIVE VT

90-95% HAS RBBB AND LEFT SUPERIOR-AXIS MORPHOLOGYTHE REMAINDER OF PATIENTS HAVE VT WITH RBBB AND RIGHT INFERIOR-AXIS MORPHOLOGYRS INTERVAL IS USUALLY 60-80 ms (in VTs associated with structural heart disease RS is longer than 100 ms )

Dr Mostafa Hekmat

60

Slide61

CPVT

Inherited VTChildren and adolescentsWithout any overt structural heart disease.Patients typically present with syncope or aborted sudden deathHighly reproducible, stress-induced VTBidirectional Mutations of the ryanodine receptor gene result in an autosomal dominantMutations in the calsequestrin gene result in an autosomal recessive

Dr Mostafa Hekmat

61

Slide62

CPVT

The treatment of choice is beta blockers and an ICDSympathectomyAvoid vigorous exercise

Dr Mostafa Hekmat

62

Slide63

Dr Mostafa Hekmat

63

Slide64

Dr Mostafa Hekmat

64

Slide65

Long QT Syndrome

Slide66

Dr Mostafa Hekmat

66

Slide67

Congenital LQTS

The congenital LQTS is a rare disorder (incidence 1:10,000 to 1:15,000) characterized byProlongation of the Q–T interval on the surface ECGRecurrent syncopeSudden death

Dr Mostafa Hekmat

67

Slide68

Congenital LQTS

Romano-Ward syndromeAutosomal dominant inheritanceOnly Cardiac ArrhythmiasJervell and Lange-Nielson syndromeAutosomal recessive inheritance Cardiac ArrhythmiasCongenital deafness.Andersen-Tawil syndromeVentricular ArrhythmiasPeriodic paralysis & Facial/Skeletal dysmorphism

68

Slide69

The acquired form of long-QT

QuinidineProcainamideN-acetylprocainamideSotalolAmiodaroneDisopyramidePhenothiazinesTricyclic antidepressantsErythromycin Pentamidine

Cisapride Probucol Hypokalemia Hypomagnesemia liquid protein dietStarvation central nervous system lesionsBradyarrhythmias cardiac ganglionitismitral valve prolapse

Dr Mostafa Hekmat

69

Slide70

LQTS

Torsades de pointes commonly developsIn patients with the acquired form during periods of bradycardia or after a long pause in the R-R intervalWhereas those with the idiopathic form can have a sinus tachycardia preceding the ventricular arrhythmia.

Dr Mostafa Hekmat

70

Slide71

Dr Mostafa Hekmat

71

Slide72

Dr Mostafa Hekmat

72

Slide73

K or Na

The principal abnormality in LQTS is prolongation of action potential duration caused by a reduction in outward potassium current (LQT1 and LQT2)or, less commonly, a persistent inward sodium current during the plateau phase (LQT3).

Dr Mostafa Hekmat

73

Slide74

Action potential prolongation  development of early after depolarizations  triggered action potential  premature beat  can initiate a polymorphic VT known as torsades de pointes,Which underlies the clinical symptoms of palpitations, syncope, or sudden death due to VF.

Dr Mostafa Hekmat

74

Slide75

Dr Mostafa Hekmat

75

Slide76

Dr Mostafa Hekmat

76

Slide77

Dr Mostafa Hekmat

77

Slide78

Triggers of cardiac event 1

The classic description of events in LQTS involves exercise- or emotion-induced clinical events.Symptoms often begin in adolescence, though they may begin earlier in LQT1.

Dr Mostafa Hekmat

78

Slide79

Triggers of cardiac event 2

Adrenergic Stimuli in LQTS with Loss of function of K (iKs-LQTS1 , iKr-LQTS2) TDPAdrenergic Stimuli  Transmural disturbances Β Blocker are useful in LQTS1 & LQTS2

Dr Mostafa Hekmat

79

Slide80

Dr Mostafa Hekmat

80

Slide81

LQTS1

Rhythm disturbances mainly occur during sports especially swimming

Dr Mostafa Hekmat

81

Slide82

LQTS 2

Rhythm disturbances mainly triggered by Auditory stimuli

Dr Mostafa Hekmat

82

Slide83

LQTS 3

Malfunction of iNaL , Symptom mostly occur at rest or during nightNo adrenergic triggersB Blockers Contraindicated

Dr Mostafa Hekmat

83

Slide84

In

10% of patient SCD is the first & tragic symptom.LQTS1 and LQTS2 are more cardiac eventsBenign cardiac symptoms such as palpitation and syncope degenerate more easily to SCD in LQTS3

Dr Mostafa Hekmat

84

Slide85

LQTS

The hallmark of this condition is prolongation of the QTc greater than 460 ms, QTc may be normal in up to 1/3 of genotype-positive patients.

Dr Mostafa Hekmat

85

Slide86

LQTS

Causes of considerable temporal variation in QTcRepolarization is affected by factors such asSympathetic outflowElectrolyte balancePharmacologic agents

Dr Mostafa Hekmat

86

Slide87

LQTS

The mean QTc does not differ between the LQT1, LQT2, and LQT3 typesBut is significantly longer in Jervell and Lange-Neilson syndrome.Other electrocardiographic abnormalities that may be found in LQTS include ST–T wave changesU waves, T wave alternansIncreased QT dispersionSinus bradycardia

Dr Mostafa Hekmat

87

Slide88

FactorMechanismBradycardia↑APD↑APD prolongation withclass III agentsDrugs Mainly IKr IKs blockadeElectrolyte disorders (hypokalemia, hypomagnesemia, hypocalcemia) Hypokalemia ↓IKr and ↑IKrsensitivity to pharmacologicblockersLeft ventricular hypertrophy/failure ↓K+ currents (Ito, IKr, IKs)Changes to ICaL andintracellular Ca2+Miscellaneous (e.g., anorexia,cerebrovascular disease,hypothyroidism, ionic contrastmedia)? Reduced repolarization reserveLong QT syndrome

Dr Mostafa Hekmat

88

Slide89

MANAGEMENT

For patients who have idiopathic long-QT syndrome but not SyncopeComplex ventricular arrhythmias, Family history of sudden cardiac deathQTc longer than 500 milliseconds,No therapy or treatment with a beta blocker is generally recommended.

Dr Mostafa Hekmat

89

Slide90

MANAGEMENT

In asymptomatic patients with Complex ventricular arrhythmias,Family history of early sudden cardiac deathQTc longer than 500 millisecondsBeta adrenoceptor blockers at maximally tolerated doses are recommended.PPM to prevent the bradycardia or pauses that may predispose to the development of TDP may be indicated

Dr Mostafa Hekmat

90

Slide91

MANAGEMENT

In patients with syncope caused by ventricular arrhythmias or aborted sudden death, an ICD is warranted.Concomitant beta blockersOverdrive atrial pacing (via the ICD) to minimize the frequency of ICD discharges

Dr Mostafa Hekmat

91

Slide92

MANAGEMENT

Most competitive sports are contraindicated for patients with the congenital long-QT syndromeFor patients with the acquired form and TDP, intravenous Mg and atrial or ventricular pacing are initial choices.

Dr Mostafa Hekmat

92

Slide93

Survival is dramatically improved by

Aggressive treatment with β-Blocker drugsCardiac pacingLeft cervical sympathectomyImplantable cardioverter defibrillator (ICD).

Dr Mostafa Hekmat

93

Slide94

Short QT

Syndrome

Slide95

Definition

QT of less than 350 milliseconds at rates of less than 100 beats/min

Dr Mostafa Hekmat

95

Slide96

Short-QT

interval has recently been identified to carry an increased risk of sudden death due to VFOne of the syndromes responsible for “idiopathic VF”

Dr Mostafa Hekmat

96

Slide97

Causes

Hyperkalemia Hypercalcemia Hyperthermia Acidosis Digitalis Genetic abnormalities

Dr Mostafa Hekmat

97

Slide98

Treatment

ICDs are considered the treatment of choice in symptomatic patients to prevent sudden cardiac death. Quinidine

Dr Mostafa Hekmat

98

Slide99

Dr Mostafa Hekmat

99